CClinicalTrials.gg
CompletedNCT01028833Updated Jan 14, 2016

Effects of Power Mobility on Young Children With Severe Motor Impairments

A Phase 2 interventional study of Power mobility in Cerebral Palsy, Arthrogryposis and Spinal Muscular Atrophy, sponsored by University of Oklahoma. Completed at 1 site in United States. Open to participants aged 14 Months to 30 Months. Per ClinicalTrials.gov, last updated 2016-01-14.

Sponsored by University of Oklahoma · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
41
Allocation
Randomized
Ages
14 Months to 30 Months
Sex
All
01

Study summary

The purpose this study is to determine the effects of power mobility on the development and function of young children of young children whose severe physical disabilities limit their exploratory behaviors and may unnecessarily restrict their cognitive, communication, and social-emotional development.

02

Conditions studied

  • Cerebral Palsy
  • Arthrogryposis
  • Spinal Muscular Atrophy
  • Other Central Nervous System or Musculoskeletal Disorders

Keywords

  • power wheelchairs
  • power mobility
  • young children
03

In context

Musculoskeletal Diseases

657 studies on the registry are indexed under Musculoskeletal Diseases; 159 are open to participants now.

This study's enrollment of 41 is below the median of 73 across 438 interventional studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

University of Oklahoma is the lead sponsor of 424 studies on the registry; 99 are open to participants now.

Of its 42 completed or terminated interventional studies of FDA-regulated products, 16 (38%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Months to 30 Months
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Must be between 14- and 30-months of age
  • Must have clinical diagnosis of a motor impairment that prevents functional independent mobility
  • Must have adequate vision and hearing to use power mobility device safely
  • Must have cognitive abilities equivalent to a 12-month level or alertness and interest in the environment that suggests a trial of power mobility is warranted
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
41 participants (actual)

Study arms

  • Experimental
    Power mobility

    Intervention included provision of power wheelchair and power mobility training program. Project staff will use structured power mobility training program to teach the children to use the power mobility devices. Project staff will schedule 1-hour sessions with each family 3 times per week for the first month of the project and will decrease in the following manner as the child becomes proficient and develops basic wheelchair maneuvering skills: two one-hour session per week for 4 weeks; one one-hour session per week for 4 weeks; two one-hour sessions per month for 4 weeks; one one-hour session per month for the remainder of the study.

    Other: Power mobility

  • No intervention
    Control

    Children in the control group will not receive any additional intervention, but will continue to receive the early intervention or other services they were receiving prior to enrollment in this study.

Interventions

  • OtherPower mobility

    Project staff will use structured power mobility training program to teach the children to use the power mobility devices. Project staff will schedule 1-hour sessions with each family 3 times per week for the first month of the project and will decrease in the following manner as the child becomes proficient and develops basic wheelchair maneuvering skills: two one-hour session per week for 4 weeks; one one-hour session per week for 4 weeks; two one-hour sessions per month for 4 weeks; one one-hour session per month for the remainder of the study.

06

What researchers measure

Primary outcomes

  1. Merrill-Palmer-Revised

    Time frame: Entry, 6-months, and 12-months

  2. Pediatric Evaluation of Disability Inventory

    Time frame: Entry, 6-months, 12-months

Secondary outcomes

  1. Child Health Status

    Time frame: Entry

  2. Two-position object permanence test

    Time frame: Entry, 6 months, 12 months

  3. Nonspeech Test

    Time frame: Entry, 6 month, 12 months

  4. Home Observation Measure of the Environment

    Time frame: Entry, 6 months, 12 months

  5. Parenting Stress Inventory

    Time frame: Entry, 6 months, 12 months

  6. Center for Epidemiologic Studies Depression Scale (CES-D)

    Time frame: Entry, 6 months, 12 months

  7. Hollingshead Scale

    Time frame: Entry

07

Study locations

1 site
  • Department of Rehabilitation Sciences, Lee Mitchener Tolbert Center for Develompental Disabilities
    Oklahoma City, Oklahoma 73117, United States
08

References and documents

Publications

  • Mockler SR, McEwen IR, Jones MA. Retrospective Analysis of Predictors of Proficient Power Mobility in Young Children With Severe Motor Impairments. Arch Phys Med Rehabil. 2017 Oct;98(10):2034-2041. doi: 10.1016/j.apmr.2017.05.028. Epub 2017 Jul 5. PubMed 28688787 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01028833
Lead sponsor
University of Oklahoma
Responsible party
Sponsor
First posted
Dec 9, 2009
Start date
Nov 2008
Primary completion
Dec 2012
Completion
Dec 2012
Last update
Jan 14, 2016

Study contacts

Maria A. Jones, PT, PhD
principal investigator · University of Oklahoma

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion